Navigation Links
BioInformatics, LLC New Market Report - Next Generation Sequencing
Date:10/18/2011

ARLINGTON, Va., Oct. 18, 2011 /PRNewswire/ -- BioInformatics, LLC announces the release of their newest market report:

The Global Outlook for Next Generation Sequencing:  Usage, Preferences and Budgets (11-003)

This worldwide study of the academic and pharma/biotech sectors provides a market analysis of next generation sequencing (NGS) and an assessment of the brand equity and brand positioning of companies providing NGS instrumentation and consumables.  To better understand the current market for NGS technologies, the report includes an in-depth exploration of NGS technologies currently deployed, workflow and types of applications.  

The following suppliers' products were provided as some of the answer choices in the survey:

Agilent Technologies
Fluidigm
Helicos Biosciences
Idaho Technology, Inc.
Illumina
Invitrogen (Life Technologies)
Ion Torrent (Life Technologies)
Life Technologies/SOLiD Sequencing
NuGEN
Pacific Biosciences
RainDance Technologies
Roche/NimbleGen

"Beyond the traditional sampling of genome content, a diversity of applications are emerging for next generation sequencing technologies, firmly securing its place at the forefront of scientific discovery," states Tamara Zemlo, Ph.D., MPH, Vice President of Advisory Services.  Dr. Zemlo adds that: "The market analysis presented in this report will provide life science suppliers with the guidance they need to keep up with such a rapidly advancing field."

To learn more about this report, a complimentary Executive Summary is available at:
http://www.gene2drug.com/index.php?page=reports&id=220

ABOUT BIOINFORMATICS, LLC

BioInformatics, LLC is the premier research and advisory firm serving the life science industry.  By leveraging our professional social network of more than 66,000 life scientists, we have supported more than 500 companies and provided insights that lead to better business decisions.  Our assignments include assessing the size and attractiveness of markets, optimizing product configurations and pricing, validating corporate acquisitions, measuring customer loyalty, and evaluating brand strength and positioning.

For more information contact:

Mary Follin
Manager, Marketing/Sales
BioInformatics, LLC
2111 Wilson Blvd., Suite 250
Arlington, VA  22201
703.778.3080 x13 (phone)
m.follin@gene2drug.com

http://www.gene2drug.com/


'/>"/>
SOURCE BioInformatics, LLC
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. BioInformatics, LLC Offers Solutions for Optimizing Service and/or Maintenance Contracts
2. BioInformatics, LLC Studies Effective Strategies for Scientific Publishing in a Web 2.0 World
3. BioInformatics, LLC New Report -- The Market for Antibodies: Keys to Success for Commercial Suppliers, Vol. III
4. BioInformatics, LLC New Report - The Market Outlook for Research Products in FY2010
5. BioInformatics, LLC New Market Report - Genomics Technologies
6. BioInformatics, LLC New Market Report - Membrane Protein Structure
7. Concentric Medical(R) Announces Co-Marketing Agreement With InTouch Health(R) to Advance Acute Ischemic Stroke Care
8. XTL Biopharmaceuticals Receives Notice of Non-Compliance with Nasdaq Marketplace Rule Due to Changes in Board Composition
9. BMP Sunstone Receives Production License from the SFDA to Manufacture and Market Pediatric Multivitamin Granules in the PRC
10. Huifeng Bio-Pharmaceutical (HFGB) to Attend CPhI South America 2008 Pharmaceutical Conference; The First CPhI Conference to be held in the Emerging Market of Brazil
11. Oncothyreon announces receipt of notice of non-compliance with market value of listed securities standard for listing on The NASDAQ Global Market
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... ... June 27, 2016 , ... Newly created ... services and solutions to the healthcare market. The company's primary focus is on ... sales and marketing strategies that are necessary to help companies efficiently bring their ...
(Date:6/24/2016)... , June 24, 2016 Epic Sciences ... detects cancers susceptible to PARP inhibitors by targeting ... cells (CTCs). The new test has already been ... in multiple cancer types. Over 230 ... damage response pathways, including PARP, ATM, ATR, DNA-PK ...
(Date:6/23/2016)... CAMBRIDGE, Mass. , June 23, 2016 /PRNewswire/ ... the development of novel compounds designed to target ... compound, napabucasin, has been granted Orphan Drug Designation ... in the treatment of gastric cancer, including gastroesophageal ... cancer stemness inhibitor designed to inhibit cancer stemness ...
(Date:6/23/2016)... , June 23, 2016  The Prostate Cancer Foundation (PCF) ... precise treatments and faster cures for prostate cancer. Members of the Class of ... 15 countries. Read More About the Class of 2016 ... ... ...
Breaking Biology Technology:
(Date:4/28/2016)... 2016 First quarter 2016:   ... with the first quarter of 2015 The gross margin ... (loss: 18.8) and the operating margin was 40% (-13) ... Cash flow from operations was SEK 249.9 M (21.2) , ... unchanged, SEK 7,000-8,500 M. The operating margin for 2016 ...
(Date:4/15/2016)... , April 15, 2016 ... "Global Gait Biometrics Market 2016-2020,"  report to their ... ) , ,The global gait biometrics market ... 13.98% during the period 2016-2020. Gait ... which can be used to compute factors that ...
(Date:3/29/2016)... 2016 LegacyXChange, Inc. (OTC: ... SelectaDNA/CSI Protect are pleased to announce our successful effort ... variety of writing instruments, ensuring athletes signatures against counterfeiting ... from athletes on LegacyXChange will be assured of ongoing ... Bill Bollander , CEO states, "By ...
Breaking Biology News(10 mins):